Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
Regeneron Breaks Ground on $1.8B NY Expansion Project
BioSpace
Thu, 06/23/22 - 10:41 am
Regeneron
New York
Regeneron's Eylea could lose 30% of its patients to Roche's Vabysmo over the next year: analyst survey
Fierce Pharma
Mon, 06/13/22 - 09:46 pm
Regeneron
Eylea
Vabysmo
Roche
wet-AMD
FDA approves Sanofi and Regeneron’s Dupixent for atopic dermatitis in young children
Pharmaceutical Business Review
Wed, 06/8/22 - 10:44 am
Sanofi
Regeneron
FDA
pediatric
atopic dermatitis
Dupixent
Regeneron purchases Sanofi’s stake in Libtayo collaboration
Biopharma Reporter
Thu, 06/2/22 - 10:27 am
Regeneron
Sanofi
Libtayo
Regeneron's cholesterol drug war heats up with lawsuit over Amgen's 'illegal' bundling scheme
Fierce Pharma
Wed, 06/1/22 - 07:36 pm
Regeneron
Amgen
FDA
antitrust
legal
Repatha
Praluent
FDA grants speedy review to Dupixent rare skin disease
Pharmaforum
Tue, 05/31/22 - 10:43 am
Sanofi
Regeneron
Dupixent
prurigo nodularis
FDA
Why Regeneron Investors Shouldn't Fear Its Patent Cliff
Motley Fool
Thu, 05/26/22 - 10:08 am
Regeneron
patents
patent cliff
Eylea
Sanofi's Dupixent scores big as the first FDA-approved treatment for eosinophilic esophagitis
Fierce Pharma
Sun, 05/22/22 - 09:15 pm
Sanofi
Regeneron
Dupixent
FDA
eosinophilic esophagitis
Is Regeneron In Trouble After Sales Declined 40% In a Single Quarter?
Motley Fool
Thu, 05/12/22 - 10:15 am
Regeneron
earnings
The 12 Top Biotech Companies Hiring Now
BioSpace
Tue, 05/10/22 - 10:26 pm
biotech
life sciences
hirings
Regeneron
Pfizer
Amgen
AbbVie
Moderna Therapeutics
CSL Behring
Waters Corporation
Daiichi Sankyo
Gilead Sciences
Grail
Emergent BioSolutions
resilience
Regeneron tries to shake off fall in COVID drug sales with first quarter earnings
BioPharma Dive
Wed, 05/4/22 - 05:44 pm
Regeneron
earnings
5 Big Pharma, Biotech Stocks Set to Beat Q1 Earnings Estimates
Yahoo/Zacks.com
Fri, 04/29/22 - 10:17 am
COVID-19
earnings
Novo Nordisk
Biogen
Regeneron
Moderna Therapeutics
Vertex Pharmaceuticals
Late-stage pain pipeline refuses to swell
EP Vantage
Tue, 04/26/22 - 10:29 pm
painkillers
Vertanical
Teva Pharmaceutical
Regeneron
Ampio Pharmaceuticals
Biogen
Eli Lilly
Vertex Pharmaceuticals
AstraZeneca
Acadia Pharmaceuticals
Regeneron CEO's pay drops 95%—but that shouldn't come as a shock
Fierce Pharma
Fri, 04/22/22 - 10:28 am
Regeneron
Pharma CEOs
executive pay
Leonard Schleifer
Regeneron sees skin cancer potential beyond PD-1s with $250M Checkmate acquisition
Fierce Biotech
Tue, 04/19/22 - 11:10 am
Regeneron
Checkmate Pharmaceuticals
M&A
skin cancer
vidutolimod
Regeneron's bid for COVID-19 drug's full approval hits snag as FDA extends review
Fierce Pharma
Thu, 04/14/22 - 10:56 am
Regeneron
REGEN-COV
FDA
COVID-19
antibodies
Hunting for next big eye disease drug, Regeneron gets deeper into gene therapies with ViGeneron pact
Fierce Biotech
Wed, 04/6/22 - 12:18 pm
Regeneron
gene therapy
ViGeneron
retinal disease
ACC 2022 – Astra’s cholesterol lowerer surprise comes just a little late
EP Vantage
Tue, 04/5/22 - 10:59 am
AstraZeneca
Ionis Pharmaceuticals
AZD8233
cholesterol
ACC
Amgen
Sanofi
Novartis
Regeneron
FDA accepts Regeneron, Sanofi’s Dupixent for priority review
Pharmaceutical Business Review
Tue, 04/5/22 - 10:53 am
Regeneron
Sanofi
Dupixent
FDA
eosinophilic esophagitis
Lilly, after making $1B bet, posts 'compelling' late-phase data on Dupixent rival
Fierce Biotech
Mon, 03/28/22 - 10:20 am
Eli Lilly
lebrikizumab
Demira
Sanofi
Regeneron
Dupixent
atopic dermatitis
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »